The goal of this clinical trial is to test the roles of dopamine and norepinephrine in
decision making related to loss aversion in the healthy population. The main question it aims
to answer is whether temporarily boosting dopamine activity or temporarily suppressing
norepinephrine activity has an impact on processing of potential gains and losses in
financial decision making, social decision making, transaction decision making and moral
decision making. Accordingly, participants will complete four decision-making tasks, namely
investment task, driving task, trading task, and die task, after taking madopar, propranolol
or placebo. Participants' psychological traits and psychiatric symptoms will be assessed once
they are enrolled before the first-session day.
Phase:
N/A
Details
Lead Sponsor:
Sir Run Run Shaw Hospital
Treatments:
Benserazide Benserazide, levodopa drug combination Levodopa Propranolol